AbbVie signs potential $2.4bn cancer immunotherapy deal with HarpoonAbbVie has signed a deal worth up to $2.4 billion with the US biotech Harpoon Therapeutics, expanding a Share XAbbVie signs potential $2.4bn cancer immunotherapy deal with Harpoonhttps://pharmaphorum.com/news/abbvie-signs-potential-2-4bn/